- UPDATED! Thoroughly updated drug content reflects the very latest Health Canada drug approvals, withdrawals, and therapeutic uses, as well as corresponding updated nursing content.
- NEW! Coverage of current top-of-mind topics includes pharmacology as it pertains to palliative care; the legalization of marihuana for both medical and recreational purposes; issues surrounding the use and misuse of fentanyl and the take-home distribution of naloxone kits used to tackle the growing fentanyl crises; and more.
- NEW! The latest Canadian statistics, research, legislation, regulations, and clinical practice guidelines have been incorporated throughout the text as well as content reflecting the 2017 CNA Code of Ethics, updated references, and more.
- NEW! Additional examination review questions help readers more thoroughly prepare for credentialing exams.
- NEW! Updated case studies better reflect the diverse Canadian population.
- NEW! Expanded visual program incorporates more diagrams, graphs, charts and photos throughout the text to accompany difficult concepts and theories and help facilitate learning.
- NEW! Incorporation of the Truth and Reconciliation Commission of Canada's Calls to Action in chapters 4 and 7 now covers Indigenous health and healing practices, an explanation of the Indigenous medicine wheel, and alternative medicinal interventions.
Auflage
Sprache
Verlagsgruppe
Elsevier HealthScience EN
Illustrationen
Approx. 311 illustrations (311 in full color)
ISBN-13
978-0-323-69481-0 (9780323694810)
Schweitzer Klassifikation
Dr. Kara Sealock is a tenured, Professor in the Faculty of Nursing, University of Calgary with a focus in adult education. She has extensive experience teaching students from years 1 to 4 in both clinical and theory. Dr. Sealock is passionate about pathophysiology, assessment, and pharmacology content addressing populations across the lifespan, supporting students as they transition from student to practitioner, and student success on NCLEX-RN. To the educator role, Dr. Sealock brings strong clinical nursing experience in adult critical care (ICU/CCU), medical-surgical, gerontology, and clinical research (cardiovascular and endocrinology). Dr. Sealock's research interests include adult learning with specific attention to cognitive levels of learning in clinical and theoretical environments (critical thinking/clinical judgement), student success on NCLEX-RN and faculty development, relational inquiry, and empathy. She has presented at the local, provincial, and national level. Dr. Sealock has been an NCSBN item writer for the NCLEX and NGN. She is also the NGN faculty training lead at the University of Calgary. Along with being one of the co-authors of our Lilley's Pharmacology for Canadian Health Care Practice, Dr. Sealock serves as Elsevier's Canadian NCLEX-NGN subject matter expert. Dr. Sealock holds the 2019 Faculty of Nursing, Pursuit of Excellence Award- Committee's Choice, and was recently awarded the 2022/23 Pat Griffin Research Grant by the Canadian Association of Schools of Nursing (CASN).Cydnee Seneviratne, RN, BScN, MN, PhDLinda Lilley, RN, PhD, is University Professor and Associate Professor Emeritus at the School of Nursing at Old Dominion University in Norfolk, Virginia.Julie S. Snyder, MSN, RN, MEDSURG-BC, teaches at the School of Nursing at Old Dominion University in Norfolk, Virginia.
Part One: Pharmacology Basics1. Nursing Practice in Canada and Drug Therapy2. Pharmacological Principles3. Legal and Ethical Considerations4. Patient Focused Considerations5. Gene Therapy and Pharmacogenomics6. Medication Errors: Preventing and Responding7. Patient Education and Drug Therapy8. Over-the-Counter Drugs and Natural Health Products9. Vitamins and Minerals10. Principles of Drug AdministrationPart Two: Drugs Affecting the Central Nervous System11. Analgesic Drugs12. General and Local Anaesthetics13. Central Nervous System Depressants and Muscle Relaxants14. Central Nervous System Stimulants and Related Drugs15. Antiepileptic Drugs16. Antiparkinsonian Drugs17. Psychotherapeutic Drugs18. Substance MisusePart Three: Drugs Affecting the Autonomic Nervous System19. Adrenergic Drugs20. Adrenergic-Blocking Drugs21. Cholinergic Drugs22. Cholinergic Blocking DrugsPart Four: Drugs Affecting the Cardiovascular and Renal Systems23. Antihypertensive Drugs24. Antianginal Drugs25. Heart Failure Drugs26. Antidysrhythmic Drugs27. Coagulation Modifier Drugs28. Antilipemic Drugs29. Diuretic Drugs30. Fluids and ElectrolytesPart Five: Drugs Affecting the Endocrine System31. Pituitary Drugs32. Thyroid and Antithyroid Drugs33. Antidiabetic Drugs34. Adrenal Drugs35. Women's Health Drugs36. Men's Health DrugsPart Six: Drugs Affecting the Respiratory System37. Antihistamines, Decongestants, Antitussives, and Expectorants38. Respiratory DrugsPart Seven: Drugs Affecting the Gastrointestinal System and Nutrition39. Acid-Controlling Drugs40. Antidiarrheal Drugs and Laxatives41. Antiemetic and Antinausea Drugs42. Nutritional SupplementsPart Eight: Anti-Infective and Anti-Inflammatory Drugs43. Antibiotics Part 1: Sulfonamides, Penicillins, Cephalosporins, Macrolides, and Tetracyclines44. Antibiotics Part 2: Aminoglycosides, Fluoroquinalones, and Other Drugs45. Antiviral Drugs46. Antitubercular Drugs47. Antifungal Drugs48. Antimalarial, Antiprotozoal, and Anthelmintic Drugs49. Anti-Inflammatory and Antigout DrugsPart Nine: Immune and Biological Modifiers and Chemotherapeutic Drugs50. Immunosuppressant Drugs51. Immunizing Drugs and Pandemic Preparedness52. Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle - Specific Drugs53. Antineoplastic Drugs Part 2: Cell Cycle - Nonspecific and Miscellaneous Drugs54. Biological Response - Modifying Drugs and Antirheumatic DrugsPart Ten: Miscellaneous Therapeutics: Hematological, Dermatological, Ophthalmic, and Otic Drugs55. Anemia Drugs56. Dermatological Drugs57. Ophthalmic Drugs58. Otic Drugs Appendix: Pharmaceutical AbbreviationsAnswers to Examination Review QuestionsCase Study Photo CreditsBibliographyIndex of Glossary TermsDrug IndexGeneral IndexSpecial Features
